The Chemours Company
CC
$12.37
-$0.07-0.56%
NYSE
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 86.00M | 76.00M | 114.00M | -331.00M | -238.00M |
Total Depreciation and Amortization | 301.00M | 297.00M | 295.00M | 299.00M | 307.00M |
Total Amortization of Deferred Charges | 12.00M | 12.00M | 11.00M | 10.00M | 9.00M |
Total Other Non-Cash Items | 20.00M | 55.00M | -111.00M | -170.00M | -142.00M |
Change in Net Operating Assets | -1.05B | -729.00M | -606.00M | 582.00M | 620.00M |
Cash from Operations | -633.00M | -289.00M | -297.00M | 390.00M | 556.00M |
Capital Expenditure | -360.00M | -386.00M | -396.00M | -381.00M | -370.00M |
Sale of Property, Plant, and Equipment | 3.00M | -130.00M | 8.00M | 8.00M | 5.00M |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | 138.00M | 138.00M | 138.00M | 138.00M |
Other Investing Activities | 4.00M | 2.00M | 7.00M | 2.00M | -2.00M |
Cash from Investing | -353.00M | -376.00M | -243.00M | -233.00M | -229.00M |
Total Debt Issued | 699.00M | 120.00M | 771.00M | 775.00M | 771.00M |
Total Debt Repaid | -604.00M | -123.00M | -390.00M | -397.00M | -378.00M |
Issuance of Common Stock | 9.00M | 9.00M | 18.00M | 18.00M | 19.00M |
Repurchase of Common Stock | -3.00M | -4.00M | -22.00M | -58.00M | -88.00M |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -148.00M | -149.00M | -148.00M | -149.00M | -149.00M |
Other Financing Activities | 11.00M | 21.00M | -4.00M | -3.00M | -3.00M |
Cash from Financing | -36.00M | -126.00M | 225.00M | 186.00M | 172.00M |
Foreign Exchange rate Adjustments | -22.00M | 10.00M | -11.00M | -11.00M | 4.00M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -1.04B | -781.00M | -326.00M | 332.00M | 503.00M |